Lienwit
The computed 12-month bankruptcy probability of Lienwit is 0.1% (very low). The 2025 annual accounts show equity of €104k and a net result of €103k. Equity is growing by ~35.6% per year across the filed fiscal years. Its solvency ranks better than 95% of 2185 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €104k |
| Net result | €103k |
| Better than sector | 95% |
| Active | 4 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 96.6% | 58.1% | |
| Net result | €103k | €60k | |
| Equity | €104k | €74k | |
| Gross operating margin | €136k | €96k | |
| Total assets | €108k | €186k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €136k |
| Net profit | €103k |
| Cash flow | €107k |
| Staff costs | - |
| Income taxes | €31k |
| Dividends | €182k |
| Total assets | €108k |
| Equity | €104k |
| Debt | €4k |
| of which ≤ 1y | €2k |
| of which > 1y | - |
| Working capital | €94k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 44.21 |
| Quick ratio | 44.21 |
| Working capital ratio | 87.0% |
| Solvency | 96.6% |
| Debt / equity | 0.03 |
| Long-term debt ratio | - |
| Interest coverage | 71.96 |
| Gross margin | - |
| Net margin | - |
| ROA | 95.7% |
| ROE | 99.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €108k |
| Fixed assets | 21/28 | €12k |
| Tangible fixed assets | 22/27 | €12k |
| Current assets | 29/58 | €96k |
| Amounts receivable within one year | 40/41 | €10k |
| Investments | 50/53 | €40k |
| Cash & bank | 54/58 | €31k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €108k |
| Equity | 10/15 | €104k |
| Contributions / capital | 10/11 | €1k |
| Reserves | 13 | €103k |
| Amounts payable | 17/49 | €4k |
| Amounts payable within one year | 42/48 | €2k |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €136k |
| Operating result | 9901 | €132k |
| Financial income | 75 | €3k |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €134k |
| Income taxes | 67/77 | €31k |
| Net result for the period | 9904 | €103k |
| Result to be appropriated | 9905 | €103k |
| NACE primary | General medical practice(86210) |
| Legal form | Private limited company(610) |
| Incorporation | 23-02-2022 |
| Status | Active |
| Postal code | 8490 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31027D0125/00G004 | Flanders | 541 m² | 1 · 167 m² | 4.0 m · 1 fl. |
| 31012C0467/00K002 | Flanders | 350 m² | 1 · 98 m² | 0.0 m |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
15-06-2026 General meeting · Officer appointment · Act object
- Filing: 2026-06-05 · Lienwit
- General meeting: 2026-05-19 · Lienwit
- Officer appointment: role: additionele bestuurder, term: 6 years, start_date: 2026-06-05 · Lienwit
- Officer appointment: role: Bestuurder · Lienwit
- Publication: 2026-06-15
- Act object: Benoeming
Technical details
{
"facts": [
{
"type": "filing",
"quote": "NEERLEGGING TER GRIFFIE VAN DE ONDERNEMINGSRECHTBANK GENT afdeling BRUGGE 05 JUNI 2026",
"value": "2026-06-05",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "De bijzondere algemene vergadering van 19 mei 2026",
"value": "2026-05-19",
"object": null,
"subject": "e1"
},
{
"type": "officer_appointment",
"quote": "de benoeming van de heer Olivier Maenhout tot additionele bestuurder ... met ingang op 5 juni 2026 en voor een periode van zes jaar",
"value": {
"role": "additionele bestuurder",
"term": "6 years",
"start_date": "2026-06-05"
},
"object": "e2",
"subject": "e1"
},
{
"type": "officer_appointment",
"quote": "Mevrouw Lien Wittevrongel Bestuurder",
"value": {
"role": "Bestuurder"
},
"object": "e3",
"subject": "e1"
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 15/06/2026",
"value": "2026-06-15",
"object": null,
"subject": null
},
{
"type": "act_object",
"quote": "Onderwerp akte: Benoeming",
"value": "Benoeming",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1105,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0782.541.164",
"kind": "company",
"name": "Lienwit",
"attrs": {
"seat": "Klaverveld 27, 8490 Jabbeke",
"legal_form": "Besloten Vennootschap"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Olivier Maenhout",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Lien Wittevrongel",
"attrs": {}
}
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Lienwit |